The rate of endometrial cancer in Australia has almost doubled in two decades, with the survival rate alarmingly decreasing. But there is some fresh hope for women battling the disease, with a new treatment added to the Pharmaceutical Benefits Scheme | Chloe Bouras

This is a big blow given all the excellent work that VCCC Alliance led by Grant have achieved Chief Executive Officer VCCC Alliance Sanchia Aranda AM, RN, PhD.

𝐈𝐭’𝐬 𝐨𝐮𝐫 𝐛𝐢𝐫𝐭𝐡𝐝𝐚𝐲 and we’re celebrating with this exceptional spread in today’s Herald Sun V Weekend magazine – with cover stars DrDavid Speakman OAM, breast and melanoma specialist and former Chief Medical Officer, and researcher Dr Dineika Chandra.

1/5

In the news today, Peter Mac's Professor Sarah-Jane Dawson is working with University of Melbourne's A/Prof RichTothill to develop a new liquid biopsy test to provide rapid diagnosis for #Cancer of the Unknown Primary patients.

Read more: petermac.org/about-us/news-…

NEW PODCAST: All we want for #valentinesday is... less silence about #endometrialcancer

Linda Mileshkin chats to us about current treatments, shame, stigma and the #ADELE trial

Listen online: t.ly/dvAlD, Apple: t.ly/s5bQ7 and other streaming apps

Calling all members 📢

Nominations are open for ANZGOG's Recognition Awards 2024 🎗️

Acknowledge those who have gone above and beyond in their dedication to advancing gynaecological cancer research.

Nominations close on 29 February.

Learn more:
anzgog.org.au/nominations-op…

Our Director of Medical Oncology Linda Mileshkin , joined the Oncology News Australia podcast to discuss new treatment options, clinical trials and collaborative research efforts for #endometrialcancer .

Listen where you get your podcasts, or click the link: oncologynews.com.au/tumour-stream/…

ANZGOG member Prof Linda Mileshkin recently appeared on the Oncology News Australia Podcast episode 'Unpacking Endometrial Cancer', discussing new treatment options, the ADELE study, and collaborative research efforts such as the EDEN Initiative.

Listen here - oncologynews.com.au/tumour-stream/…

REGISTER: thelimbic.com/oncology/key-a…
An expert panel provides important updates in Cancer of Unknown Primary, focusing on practice-shaping data presented at ESMO 2023 & new recommendations on the role of genomic profiling in the diagnosis & treatment of CUP.
Linda Mileshkin

Congratulations to Amy Bennetts for 20 years of service Peter Mac Cancer Centre Thanks for all you do as our wonderful department manager of the medical oncology team to organize everything and look after us. We couldn't do what we do without you!

🚨 New paper! Shared ( #GP + oncologist) follow up for survivors of colorectal #cancer :

⚖️ non inferior QOL c/w usual care
😀 pts exposed to shared care prefer this
👍 GPs more adherent to recommended testing
💰 shared care is cheaper!

#OpenAccess below

thelancet.com/journals/eclin…

Well done to Andrea Knox for your poster at #ESMOAsia23 highlighting the real world incidence of immune-related AES when treating lung cancer with immunotherapy. Survival outcomes good but need a lot of resource to manage ⁦Ben Solomon⁩ ⁦mayhemtom⁩ ⁦

The super smart and talented Clare Scott showing some of her work highlighting that around 10% of leiomyosarcomas carry a BRCA mutation meaning these patients may benefit from treatment with a parp inhibitor if disease relapses #ESMOAsia23

A great opportunity to write an editorial about this excellent trial in The Lancet with Dr Sathya Manoharan one of our excellent medical oncology fellows from Peter Mac Cancer Centre thelancet.com/journals/lance…